13F Data
13F filer · CIK 1611353

SC ISRAEL IV GENPAR, LTD.

HERZELIA, L3 · filing since Q4 2021 · last filing Nov 14, 2024
Reported value
$17.5M
Positions
1
New / sold out
1 / 0
Added / reduced
0 / 0
Turnover
–
buys $17.5M · sells $0
Top-10 weight
100.0%

No 13F for Q2 2024, so every position this quarter shows as new.

Biggest buys vs Q2 2024

ChangeSecurityShares changeChange %Est. trade value
NewINNOVID CORP+9,697,224–+$17.5M

Biggest sells vs Q2 2024

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $117.7MQ1 2022: $106.9MQ2 2022: $29.4MQ3 2022: $48.0MQ4 2022: $30.3MQ1 2023: $25.0MQ2 2023: $19.3MQ3 2023: $22.7MQ3 2024: $17.5M
Q4 2021Q3 2024

Holdings · Q3 2024

#SecuritySharesValueWeight
1INNOVID CORPCOMMON STOCK9,697,224$17.5M100.00%